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Abstract
Background: Among human neoplasms thymomas are associated with highest frequency with
paraneoplastic autoimmune diseases.
Case presentation: A case of a 42-year-old woman with paraneoplastic pemphigus as the first
manifestation of thymoma is reported. Transsternal complete thymoma resection achieved
pemphigus regression. The clinical correlations between pemphigus and thymoma are presented.
Conclusion: Our case report provides further evidence for the important role of autoantibodies
in the pathogenesis of paraneoplastic skin diseases in thymoma patients. It also documents the
improvement of the associated pemphigus after radical treatment of the thymoma.
Introduction
Paraneoplastic pemphigus is rarely associated with thymic
neoplasms either alone or concomitantly with other
autoimmune disorders. A case of a 42-year-old woman
with paraneoplastic pemphigus as the first manifestation
of thymoma is reported. Transsternal complete thymoma
resection achieved pemphigus regression. The pathoge-
netic and clinical relationships between pemphigus and
thymoma encountered in this case are presented with the
purpose of strengthening the hypothesis that pemphigus
in the presence of a thymoma could be a thymoma-asso-
ciated autoimmune disease.
Case presentation
A 42-year-old otherwise healthy woman was admitted to
our hospital with numerous crusted, denuted and flaccid
vesiculobullous lesions over her chest, abdomen, legs,
toes and forehead (Figures 1, 2). Vesicles were also
observed on the buccal mucosa and palate. The clinical
diagnosis of pemphigus vulgaris was confirmed by
biopsy. Histological findings included interface dermati-
tis, apoptotic keratinocytes and focal areas of suprabasal
acantholysis. Therapeutic management consisted of suc-
cessive cycles of 50 mg/day of prednisone. Medical treat-
ment provided only transient relief of symptoms and
temporary reduction in clinical manifestations and on
interruption of systemic steroid the lesions reccured.
Three months later while facing a persistent pemphigus, a
chest x-ray was done and a retrosternal tumor was noted
(Figure 3). CT scans and MRI of the chest revealed a
homogeneous anterior mediastinal mass consistent with
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a thymic tumor but with no lymph node involvement
(Figure 4). In order to perform preoperative staging of the
tumor, the patient underwent CT scans of brain, abdomen
and a bone scan. All were normal. An autoimmune labo-
ratory profile proved that desmoglein-1 (anti-DSG-1)
antibodies were normal while the desmoglein-3 (anti-
DSG-3) titer reached twice the normal.
At operation through a median sternotomy, a solid
intrathymic capsulated mass was found and a thymec-
tomy was performed. Definitive pathologic examination
found a tumor measuring 6 × 5 × 5 cm occupying the infe-
rior part of the thymus gland consisting of spindle cells
populated by varying numbers of lymphocytes with
rounder epithelial cells (Figures 5, 6). No capsular
involvement was noted (Type A non invasive thymoma
according to World Health Organization classification).
The postoperative period was uneventful. The patient was
discharged home after 10 days Postoperatively anti-DSG-
1 and anti-DSG-3 showed a transient increase. At the out-
patient visit four weeks later both desmoglein antibodies
showed a significant decrease associated with almost com-
plete resolution of the cutaneous lesions. Twelve months
later she is still disease free and with no need of steroids.
Discussion
The relation between thymus disease and autoimmune
disorders is well known and established [1]. In 1987 a ret-
rospective study among 172 patients with thymoma
found fungal mucocutaneous disease as the most com-
mon thymoma-associated cutaneous disorder [2]. Two
patients in that study were noted with pemphigus and
lichen planus respectively. Since then paraneoplastic
pemphigus has been recognized as a well defined autoim-
A profile chest x-ray showing a retrosternal tumor Figure 3
A profile chest x-ray showing a retrosternal tumor.
Numerous crusted, denuted and flaccid vesiculobullous  lesions over the chest and abdomen consistent with pemphi- gus Figure 1
Numerous crusted, denuted and flaccid vesiculobul-
lous lesions over the chest and abdomen consistent 
with pemphigus.
Close view of a pemphigus lesion Figure 2
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mune syndrome characterized by autoantibody forma-
tion directed against epithelial antigens [3]. In our case
pemphigus was diagnosed first by biopsy (Figure 7) and
this has led us to further diagnostic investigation.
Serial analysis of various case reports correlate pemphigus
with thymoma and/or myasthenia gravis although in our
case there were no symptoms or signs of myasthenia
gravis [4,5]. The clinical course and titrations of antiepi-
thelial, antimuscle, and antithymus antibodies suggested
a reverse relationship between the severity of myasthenia
gravis and titers of antimuscle and antithymus antibodies,
and a parallel relationship between pemphigus vulgaris
and antiepithelial antibody.
The association of paraneoplastic pemphigus with malig-
nancy is strong. Only a handful of patients have had no
associated diagnosis. Some patients have had benign neo-
Microscopic appearance of pemphigus with epithelial cells  falling away from each other and rounding out in the fluid of  the blister Figure 7
Microscopic appearance of pemphigus with epithelial 
cells falling away from each other and rounding out 
in the fluid of the blister.
Thymic tumor consisting of spindle cells Figure 5
Thymic tumor consisting of spindle cells.
MRI of the chest revealed an anterior mediastinal mass con- sistent with a thymic tumor Figure 4
MRI of the chest revealed an anterior mediastinal 
mass consistent with a thymic tumor.
Varying numbers of lymphocytes with rounder epithelial cells  populating spindle cells consisting with a non invasive thy- moma Figure 6
Varying numbers of lymphocytes with rounder epi-
thelial cells populating spindle cells consisting with a 
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plasms, including as in our case thymoma or Castleman's
disease. Only a single patient without a tumor has met the
diagnostic criteria, yet this patient had a rapid demise and
may have died with an undiagnosed malignancy [6].
Patients have developed paraneoplastic pemphigus while
in remission of their malignancy, leading some authors to
prefer the term neoplasia-induced pemphigus.
Treatment of the underlying malignancy does not neces-
sarily halt progression of the paraneoplastic pemphigus,
although some have observed that clinical manifestations
improve as autoantibody titers decrease following resec-
tion of the tumor. This was also proved in our case, where
anti-DSG-3 showed a significant decrease associated with
almost complete resolution of the cutaneous lesions. Cir-
culating and tissue-bound antibodies in patients with this
disease are directed against a group of molecules with
sequence homology and belonging to the plakin family.
These molecules are found in the intracellular attachment
plaques of desmosomes and hemidesmosomes, and they
play a key role in intermediate filament attachment. How-
ever, the number of reported target antigens has increased
over time and varies between patients. This variability
likely accounts for the clinical heterogeneity of this dis-
ease. By immunoprecipitation, target antigens (in decreas-
ing order of incidence) include desmoglein 3, desmoglein
1, envoplakin (210 kd), periplakin (190 kd), desmo-
plakin I (250 kd), desmoplakin II (210 kd) and bullous
pemphigoid antigen I (230 kd). Plectin (> 400 kd) and an
unidentified 170-kd protein have also been found [7].
In our case the levels of pemphigus-associated antibodies
had increased postoperatively after thymectomy. In paral-
lel, decreased titer of those antibodies preceded the reso-
lution of cutaneous lesions. A similar beneficial effect of
tumor ablation has recently also been reported in the case
of Castleman's tumor, a rare lymphoproliferative disease
that is sometimes associated with paraneoplastic pemphi-
gus [8].
Conclusion
our case report provides further evidence for the impor-
tant role of autoantibodies in the pathogenesis of parane-
oplastic skin diseases in thymoma patients. It also
documents the improvement of the associated pemphigus
after radical treatment of the thymoma. Further studies
are necessary to analyze possible pathogenetic mecha-
nisms.
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